EGFR and central nervous system cancer: Numerous studies have shown that the role of autophagy in tumors can be effectively leveraged, and several regulatory factors, such as PTEN and EGFR, can not only inhibit growth but also enhance tumor sensitivity to drugs, offering new avenues for future glioma treatment.